A novel nanomicelle based on Rebaudioside A: An oral nanoplatform with enhanced nephroprotective effect of myricetin
Tian Wang, Zhen Gao, Chuanlong Guo, Wenyong Zhu

TL;DR
A new nanomicelle system based on Rebaudioside A improves myricetin's ability to protect against kidney damage caused by cisplatin.
Contribution
A novel RA-based nanomicelle delivery system enhances myricetin's nephroprotective effects against cisplatin-induced AKI.
Findings
RA-Myr nanomicelles reduced ROS accumulation and restored mitochondrial membrane potential in HK-2 cells.
In vivo, RA-Myr lowered BUN and SCr levels and reduced kidney tissue damage in cisplatin-treated mice.
RA-Myr inhibited DNA damage and the cGAS-STING pathway in cisplatin-induced AKI.
Abstract
Cisplatin-induced acute kidney injury (AKI) is a significant clinical challenge, primarily characterized by inflammatory responses and oxidative stress. This study aimed to develop a myricetin (Myr) loaded Rebaudioside A (RA) nanomicelle delivery system (RA-Myr) and investigate its nephroprotective effects both in vitro and in vivo. RA-Myr nanomicelles were prepared using a thin film hydration method. The characterization of RA-Myr included evaluating particle size, encapsulation efficiency, and stability. The antioxidant capacity of RA-Myr was assessed using the FRAP assay, and cellular uptake was evaluated using coumarin 6-loaded RA nanomicelles. The protective effects and potential mechanisms of RA-Myr on cisplatin-induced AKI were studied in HK-2 cells and male Kunming mice. RA-Myr significantly inhibited cisplatin-induced suppression of HK-2 cell proliferation, reduced ROS…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNatural product bioactivities and synthesis · Cholesterol and Lipid Metabolism · Curcumin's Biomedical Applications
